COMMUNIQUÉS West-GlobeNewswire

-
Correction: JSC Olainfarm invites to Investor Conference - Webinar to present 1st Quarter 2019 results and the company’s new management
27/05/2019 -
Ossur Hf : Transactions in relation to share buyback program
27/05/2019 -
SuperSonic Imagine to Showcase Its New Generation Ultrasound System, Aixplorer MACH 30, at the EUROSON 2019
27/05/2019 -
Kumulus Vape fera demain ses premiers pas en Bourse
27/05/2019 -
RAPPEL -- Max Domi, vedette des Canadiens de Montréal et porte-parole national de FRDJ, se joindra le 28 mai à des enfants de la région de Montréal qui vivent avec le diabète de type 1 pour avoir une discussion franche sur la maladie
27/05/2019 -
REPEAT -- Montreal Canadiens star and JDRF National Spokesperson Max Domi joins Montreal-area kids living with type 1 diabetes May 28 for a frank discussion on the disease
27/05/2019 -
Transactions under Novozymes’ stock buyback program
27/05/2019 -
Additional agenda item for Annual General Meeting of shareholders of Joint Stock Company Olainfarm to be held on June 17th, 2019
27/05/2019 -
JSC Olainfarm invites to Investor Conference - Webinar to present 1st Quarter 2019 results and the company’s new management
27/05/2019 -
Zealand Pharma to attend Jefferies and Goldman Sachs Global Healthcare Conferences
27/05/2019 -
Ossur Hf : Major shareholder announcement
27/05/2019 -
Ventura Cannabis (VCAN) Updates Investor Presentation After Reaching Several Milestones; Adds Senior Managers to Support Growth Plan; Announces Investor Meetings in Toronto
27/05/2019 -
Emerald Completes Issuance of Shares in Lieu of Cash Due for Verdélite Acquisition
27/05/2019 -
Ossur Hf : Major shareholder announcement
27/05/2019 -
Share buy-back week 21/2019
27/05/2019 -
Auxly Reports Q1 2019 Financial Results and Highlights Key Milestones
27/05/2019 -
Sequana Medical Announces Presentation of Positive DSR Clinical Proof-of-Concept Data Demonstrating Potential in Volume Overload Due to Heart Failure
27/05/2019 -
Santhera Submits Marketing Authorization Application to the European Medicines Agency for Puldysa® (Idebenone) in Duchenne Muscular Dystrophy
27/05/2019 -
BOAZ Pharmaceuticals Inc. Celebrates Sales Licence Granted In Record Time
25/05/2019
Pages